Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$221M |
| 2 |
RSPP
RSP Permian, Inc.
RSPP
|
+$166M |
| 3 |
Vulcan Materials
VMC
|
+$165M |
| 4 |
ANDV
Andeavor
ANDV
|
+$165M |
| 5 |
Apple
AAPL
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$251M |
| 2 |
Bank of America
BAC
|
+$225M |
| 3 |
WOOF
VCA Inc.
WOOF
|
+$214M |
| 4 |
K
Kellanova
K
|
+$188M |
| 5 |
Occidental Petroleum
OXY
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.61% |
| 2 | Technology | 11.6% |
| 3 | Healthcare | 11.38% |
| 4 | Energy | 10.68% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Ichor Holdings
ICHR
$2.16B
| $2.29M | ﹤0.01% |
115,573
+60,350
| +109% | +$1.01M |
|
|
ECOM
1927
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $2.29M | ﹤0.01% |
205,312
+93,300
| +83% | +$1.15M |
|
|
CXO
1928
DELISTED
CONCHO RESOURCES INC.
CXO
| $2.29M | ﹤0.01% |
17,820
-225,026
| -93% | -$30.3M |
|
|
INSY
1929
DELISTED
Insys Therapeutics, Inc.
INSY
| $2.29M | ﹤0.01% |
217,385
-119,832
| -36% | -$1.28M |
|
|
APTI
1930
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $2.28M | ﹤0.01% |
194,678
-82,442
| -30% | -$1.19M |
|
1931
Amplify Energy
AMPY
$190M
| $2.28M | ﹤0.01% |
123,476
+59,179
| +92% | +$1.19M |
|
1932
Monarch Casino & Resort
MCRI
$2.23B
| $2.27M | ﹤0.01% |
76,944
-59,828
| -44% | -$1.55M |
|
|
LUMO
1933
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.27M | ﹤0.01% |
10,476
-48,860
| -82% | -$6.98M |
|
|
DCH
1934
Dauch Corp
DCH
$1.52B
| $2.27M | ﹤0.01% |
120,886
-482,683
| -80% | -$9.63M |
|
1935
RLI Corp
RLI
$5.95B
| $2.27M | ﹤0.01% |
75,600
+774
| +1% | +$22.9K |
|
1936
Galicia Financial Group
GGAL
$7.05B
| $2.27M | ﹤0.01% |
+59,914
| New | +$2.01M |
|
1937
Columbus McKinnon
CMCO
$519M
| $2.27M | ﹤0.01% |
91,238
+25,926
| +40% | +$682K |
|
1938
Ceco Environmental
CECO
$4.12B
| $2.26M | ﹤0.01% |
215,152
+59,093
| +38% | +$712K |
|
1939
Corcept Therapeutics
CORT
$13B
| $2.26M | ﹤0.01% |
206,324
+57,862
| +39% | +$508K |
|
1940
iShares 7-10 Year Treasury Bond ETF
IEF
$43.1B
| $2.26M | ﹤0.01% |
21,363
+18,392
| +619% | +$1.93M |
|
|
TRIB
1941
Trinity Biotech
TRIB
$7.8M
| $2.25M | ﹤0.01% |
2,522
-1,300
| -34% | -$1.22M |
|
1942
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.84B
| $2.25M | ﹤0.01% |
60,806
+47,863
| +370% | +$1.73M |
|
|
ZLTQ
1943
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $2.25M | ﹤0.01% |
40,484
-75,438
| -65% | -$3.78M |
|
1944
Gorman-Rupp
GRC
$2.05B
| $2.25M | ﹤0.01% |
71,655
+65,162
| +1,004% | +$2.03M |
|
|
INWK
1945
DELISTED
InnerWorkings, Inc.
INWK
| $2.25M | ﹤0.01% |
225,815
+203,231
| +900% | +$1.97M |
|
|
ALOG
1946
DELISTED
Analogic Corp
ALOG
| $2.24M | ﹤0.01% |
29,541
-17,895
| -38% | -$1.4M |
|
|
CUTR
1947
DELISTED
Cutera, Inc.
CUTR
| $2.23M | ﹤0.01% |
107,701
+51,763
| +93% | +$1.02M |
|
1948
Citi Trends
CTRN
$576M
| $2.22M | ﹤0.01% |
130,680
+95,886
| +276% | +$1.67M |
|
1949
MACOM Technology Solutions
MTSI
$20.8B
| $2.22M | ﹤0.01% |
+45,983
| New | +$2.15M |
|
1950
TG Therapeutics
TGTX
$8.42B
| $2.22M | ﹤0.01% |
190,627
+44,901
| +31% | +$322K |
|
Similar funds
Israel Englander's Q1 2017 Portfolio in Review
As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.
Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.
By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.
- Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
- Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
- Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
- Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
- Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
- Israel Englander opened 894 new positions and closed 743 in Q1 2017.
- Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.
Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.